Healthcare

July 31, 2014

1

AHF Mourns Sierra Leone’s Dr. Khan; Criticizes Lax Global Response to Deadly Ebola Outbreak

Dr. Sheik Humarr Khan, the physician leading Sierra Leone’s response to an Ebola outbreak that has claimed the lives of over 600 people, succumbed to the disease Tuesday. Khan, who also served part-time as Medical Officer for AIDS Healthcare Foundation’s Sierra Leone Country Program, led “…heroic efforts against Ebola…and was a passionate supporter of AHF’s HIV/AIDS clinic and mentor to its staff.”


...

Continue Reading >

July 25, 2014

2

UpToDate Adds Palliative Care as a Specialty

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that it has added Palliative Care to UpToDate®, its evidence-based clinical decision support resource, marking the 22nd medical specialty available to UpToDate subscribers. The newly launched specialty covers a range of topics focused on improving symptoms and providing the best possible quality of life for patients facing serious illness.


“The"......

Continue Reading >

July 24, 2014

3

26,000 paramedics to be trained between 2014 and 2018

Some 26,000 paramedics will be trained during the period from 2014 to 2018, said Wednesday in Algiers Head of training section at the Ministry of Health, Population and Hospital Reform, Prof. Moussa Aradha.


Speaking at a press conference held at the Ministry on training and research in the health sector, Aradha revealed that a rich program of paramedic training was"...

Continue Reading >

July 24, 2014

4

The Best Heart Disease Treatment in Thailand at Phyathai Nawamin International Hospital

Heart disease is a very common disease of the world population. It’s 1 in 4 of the cause of death all nationalities and countries. Heart disease can find in all age from newborns to the elderly. Depending on the cause, as in newborns to a cause of congenital anomalies or in the elderly, the most common heart disease is coronary heart disease were found in men than in women.


...

Continue Reading >

July 24, 2014

5

PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis

Reduces Relapses, Disability Progression, and MRI Brain Lesions, with a Favorable Safety Profile Consistent with the Established Interferon Class –

– Initial Country Launches Expected to Begin in the Coming Weeks –


Today Biogen Idec (NASDAQ: BIIB) announced that the European Commission (EC) has granted marketing authorization for PLEGRIDYTM (peginterferon"......

Continue Reading >

July 22, 2014

6

Iroko Pharmaceuticals Continues to Expand Commercialization of ZORVOLEX® With New Strategic Agreement in Latin America

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that its affiliate, Iroko Pharmaceuticals Inc., signed a licensing agreement with CALOX DE COSTA RICA S.A. for the exclusive rights to market and sell ZORVOLEX® (diclofenac) capsules in specified countries in Latin America. CALOX will be responsible for obtaining regulatory and pricing approval, as well as the marketing and supply of the medication, in countries including Colombia, Costa"...

Continue Reading >

July 19, 2014

7

Natural disasters management: Algeria pleads for creation of special funds

Secretary General of Foreign Affairs Abdelhamid Bereksi pleaded, Wednesday in Brussels, for the creation of special funds by affluent countries to ensure a better coordination in emergency situations in response to natural disasters, said Thursday the ministry in a communiqué.


Speaking at theInternational Donors’ Conference for Serbia and Bosnia-Herzegovina,"...

Continue Reading >

July 19, 2014

8

Terumo BCT Opens Manufacturing Facility in Vietnam

Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced the opening of its new 91,440-square-meter facility near Ho Chi Minh City, Vietnam. The $100 million manufacturing facility supports the expansion of Terumo BCT’s business globally. When manufacturing operations begin in early 2015, the new manufacturing facility will provide increased production capacity.


Key"...

Continue Reading >

July 17, 2014

9

Blood collection campaign for Gazans to be launched soon

A blood collection campaign will be launched soon for the inhabitants of the Gaza Strip, which continues to be subjected to Israeli aggression, announced Wednesday in Algiers the head of the Algerian Red Crescent (CRA), Saida Benhabiles.


Speaking a the forum of the daily "DK News", Benhabiles said that the "campaign is initiated by the CRA in coordination with the Algerian"...

Continue Reading >

July 17, 2014

10

Boehringer Ingelheim’s Investigational Therapy Nintedanib* Receives the First FDA Breakthrough Therapy Designation in IPF

For non-U.S. Media Only

Boehringer Ingelheim today announced that for the first time the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation for a treatment in idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease. Nintedanib* is an investigational therapy currently under FDA and European Medicines Agency (EMA) review for IPF.


...

Continue Reading >